BioNTech (United States)

BioNTech (United States)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (United States), United States, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

67%


Total
Publications

251


Total Open
Publications

167


Total
Citations

8K


Open Access
Percentage

67%


Total
Publications

251


Total Open
Publications

167


Total
Citations

8K

Wikipedia

Website

download

Breakdown

21% 26% 19% 34%

Publisher Open

21%

Both

26%

Other Platform Open

19%

Closed

34%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

45%OA Journal

OA Journal 45%

53

Hybrid 23%

27

No Guarantees 32%

37

Other Platform Open

Domain 55%

61

Institution 37%

41

Preprint 34%

38

Other Internet 3%

3

Public 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
63
doaj.org OAI-PMH Repository
Institution
36
bioRxiv
Preprint
18
Research Square
Preprint
8
medRxiv
Preprint
8
ChemRxiv
Preprint
4
DOI
Other Internet
3
LA Referencia
Institution
2
Europe PMC
Domain
2
Aalborg University
Institution
2
1 / 2

Data updated 12 August 2026

Share

Share

Share